AIM IMMUNOTECH INC. Available-for-sale Securities, Amortized Cost Basis
AIM IMMUNOTECH INC. (AIM) had Available-for-sale Securities, Amortized Cost Basis of $15.99 million as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2020-11-12
- 2020-09-30: Available-for-sale Securities, Amortized Cost Basis $15.99M.
- 2020-06-30: Available-for-sale Securities, Amortized Cost Basis $6.34M.
- 2020-03-31: Available-for-sale Securities, Amortized Cost Basis $3.49M.
- 2019-09-30: Available-for-sale Securities, Amortized Cost Basis $2.11M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2020-09-30 | $15.99M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $6.34M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $3.49M 10-Q · filed 2020-05-14 | |
| 2019-09-30 | $2.11M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.90M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.49M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $1.53M 10-Q · filed 2019-11-14 | |
| 2018-09-30 | $21.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $683.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $683.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $684.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $1.77M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.97M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $2.97M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $3.46M 10-K · filed 2018-03-30 | |
| 2016-09-30 | $3.46M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $4.89M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $6.79M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $6.89M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $11.62M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $14.06M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $14.11M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $14.11M 10-K · filed 2016-03-29 | |
| 2014-09-30 | $16.28M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $17.54M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $17.54M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $17.50M 10-K · filed 2015-03-19 | $17.50M 10-K · filed 2014-03-14 |
| 2013-09-30 | $13.61M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $17.33M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $21.28M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $27.23M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $21.51M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $19.20M 10-Q · filed 2012-08-08 | |
| 2011-12-31 | $28.56M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |